This document provides information on the formulation and evaluation of gastroretentive floating tablets of Cefadroxil using natural polymers. The objectives were to prepare floating tablets using polymers to achieve sustained release, optimize polymer concentrations, and evaluate tablet properties. Cefadroxil was selected as the model drug based on its absorption window and stability in gastric pH. Xanthan gum and guar gum were chosen as natural polymers based on their matrix-forming abilities and floating properties. Tablets were prepared by direct compression using various polymer concentrations and evaluated for properties like hardness, friability, swelling index and in vitro drug release. The results showed that the formulations using natural polymers were able to float and release the drug in a sustained manner
drug execipent compatibilty studies is of prime importance for the better formulation of the new drug and also for reducing cost by verfication of the data at the earlier atage.
this presentation will give the brief explanation of the goal, importance, dteps involve to studi the drug execient compatibility studies with different examples suitable accordiingly.
drug execipent compatibilty studies is of prime importance for the better formulation of the new drug and also for reducing cost by verfication of the data at the earlier atage.
this presentation will give the brief explanation of the goal, importance, dteps involve to studi the drug execient compatibility studies with different examples suitable accordiingly.
Introduction to Dissolution equipment's, Calibration of dissolution apparatus, Dissolution procedure development and validation, Dissolution method development for generic drug products.
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Introduction to Dissolution equipment's, Calibration of dissolution apparatus, Dissolution procedure development and validation, Dissolution method development for generic drug products.
formulation and evaluation of microbeadsgurleen kaur
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
Microencapsulation has been employed to sustain the drug release, reduce or eliminate drug related adverse effects, dose intake and improve the bioavailability inspite drug undergo extensive first pass metabolism ultimately improve the compliance in pharmacotherapy of inflammation and pain.
Microencapsulation by ionotropic gelation technique is one of the widely used method for preparation of calcium alginate beads which has ability to form gels reaction with calcium salts .
It will provide you a complete journey through the routes of drug administration, with all the basics covered I hope this presentation will make your fundamentals crystal clear.
Formulation and evaluation of omeprazole floating tabletsmedicinefda
formulation and evaluation of omeprazole floating tablets, literature review and plan of work ,methods results and discussion,conclusion sample ppt http://www.medicinefda.com/
Background: The main objective of present research work is to formulate the Carbamazepine Fast Dissoving tablets. Carbamazepine, an
antiepileptic, belongs to BCS Class-II and used to control some types of seizures in the treatment of epilepsy and Neuropathic Pain by
blocking use-dependent sodium channels. Methods: The Fast Dissoving tablets of Carbamazepine were prepared employing different
concentrations of Crospovidone and Croscarmellose sodium in different combinations as a Sperdisintegrants by Direct Compression technique
using 32
factorial design. The concentration of Crospovidone and Croscarmellose sodium was selected as independent variables, X1
and X2 respectively whereas, wetting time, Disintegration time, t
50% ,t90%were selected as dependent variables. Results and Discussion:
Totally nine formulations were designed and are evaluated for hardness, friability, thickness, Assay, Wetting time, Disintegration time, Invitro
drug release. From the Results concluded that all the formulation were found to be with in the Pharmacopoeial limits and the In-vitro
dissolution profiles of all formulations were fitted in to different Kinetic models, the statistical parameters like intercept (a), slope (b) &
regression coefficient (r) were calculated. Polynomial equations were developed for Wetting time, Disintegration time, t50%, t90%. Validity of
developed polynomial equations were verified by designing 2 check point formulations (C1
, C2
). According to SUPAC guidelines the
formulation (F5
) containing combination of 9.375% Crospovidone and 9.375% Croscarmellose, is the most similar formulation (similarity factor
f
2
=82.675, dissimilarity factor f1
= 2.049 & No significant difference, t= 0.041) to marketed product (TEGRETOL-100). Conclusion: The
selected formulation (F5
) follows First order, Higuchi’s kinetics, mechanism of drug release was found to be Non-Fickian Diffusion (n= 0.665).
KEYWORDS: Carbamazepine, 3
2Factorial Design, Crospovidone , croscarmellose Sodium, Wetting Time, Disintegration Time.
Formulation and evaluation of mucoadhesive tablets of carvedilol using natura...Nausheen Fatima
Present work describes formulation and evaluation mucoadhesive tablets of Carvedilol using natural binders such as Chitosan and Guar Gum to reduce the first pass metabolism and frequency of administration.
Formulation and Evaluation of immediate release tablet in treatment of overac...BhuminJain1
Overactive bladder (OAB) is a combination of urinary symptoms that includes a sudden, strong need to urinate. The major symptom of OAB is a sudden, strong urge to urinate that you can't ignore. Leak urine or have “urge incontinence.” This means urine leaks when you feel the sudden urge to go.
Urinate frequently. You may need to go to the bathroom many times during the day.
Wake up at night to pass urine.
The cost for (branded) oral tablet 10 mg is around $411 for a supply of 30 tablets. It indicates that there is strong need of generic version for affordable healthcare.
The data shows that number of people affected with overactive bladder is 37 million.
Formulation development and invitro evaluation of lamotrigine fast dissolving...SriramNagarajan19
The present study was to formulate and evaluate oral fast dissolving Oral tablet containing Lamotrigine. Present study reveals that all the nine formulated tablet showed satisfactory tablet parameters. It can be concluded that, Oral fast dissolving tablet -containing Lamotrigine can be prepared by direct compression method. 10% CCS (FV) tablet exhibited required disintegration time and dissolution time. The drug release was about 98.7 % in 15min. The accelerated stability studies of the optimized F5 formulation indicates that the formulated oral fast dissolving tablet were unaffected after 3 months storage under accelerated conditions as there were no signs of visually distinguishable changes in appearance, disintegration time and cumulative percentage of drug release. From the present investigation it can be concluded that oral fast dissolving tablet formulation can be a potential novel drug dosage form for pediatric, geriatric and also for general population.
In the present study an attempt will be made to design oral disintegrating tablets of Sumatriptan succinate (anti migraine) by using treated agar and Croscarmellose sodium as a superdisintigrants with a view to provide a convenient means of administration to those patients suffering from difficulties in swallowing such as pediatric and geriatric patients and uncooperative mentally ill patients.
Solubility enhancement technique of BCS Class II drug by Solvent EvaporatiomKaustav Dey
I am very happy to share with you my B.Pharm Final semester Presentation. The topic of the presentation was “SOLUBILITY ENHANCEMENT TECHNIQUE OF BCS CLASS II DRUG BY SOLVENT EVAPORATION TECHNIQUE – FORMULATION & EVALUATION" which i have done under the esteemed guidance of Dr. Goutam Kumar Jena. It was a great experience to deliver this topic infront of the expert jury. I would also like thank all my teammates especially Agniv Masanta for his efforts. I hope everyone of you will like presentation and the research and efforts behind it.Thank you for giving your precious time. #research #science #thankyou #experience #share
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
1. Guided by,
Prof. Laxmi N. Jamagondi.
College of Pharmacy, Solapur
Presented by,
Pradip B. Digge.
M.Pharm II (IVth Sem)
Department of pharmaceutics
ROLL NO:013
1
“Formulation and Evaluation of Gastroretentive Floating
Tablets of Cefadroxil by Using Natural Polymers”
D.S.T.S. Mandal’s College of Pharmacy, Solapur.
2. 2
INTRODUCTION
BASIC ANATOMYAND PHYSIOLOGY OF STOMACH
MECHANISM OF FDDS
ADVANTAGES AND DISADVANTAGES OF FDDS
FACTORS AFFECTING ON GASTRIC RETENTION
APPROACHES OF GRDDS
AIM AND OBJECTIVES
NEED FOR CURRENT INVESTIGATION
PLAN OF WORK
MATERIALS AND METHODOLOGY
EXPERIMENTAL WITH RESULTS
CONCLUSION
CONTENTS
3. Introduction
3
• Floating drug delivery systems (FDDS) have a bulk density less than
gastric fluids and so remain buoyant in the stomach without affecting
the gastric emptying rate for a prolonged period of time.
• While the system is floating on the gastric contents, the drug released
slowly at the desired rate from the system.
• Floating systems can remain in the gastric region for several
hours and hence significantly increases the gastric residence time of
drugs.
• Prolonged gastric retention improves bioavailability, decreases drug
waste, and improves solubility for drugs that are less soluble in a high
pH environment.
4. Basic Anatomy and Physiology of Stomach
4
Stomach
•Fundus
•Body
•Antrum
5. Mechanism of FDDS
5
The reactions between carbonate/bicarbonate salts and citric/tartaric
acid to liberate CO2, which gets entrapped in the gellified
hydrocolloid layer of the systems thus decreasing its specific gravity
and making it to float
7. Disadvantages of FDDS
7
•The drug substances that are unstable in the acidic environment of the
stomach are not suitable candidates to be incorporated in the systems.
•These systems require a high level of fluid in the stomach for drug delivery to
float and work efficiently.
•Gastric retention is influenced by many factors such as gastric motility , pH
and presence of food. These factors are never constant and hence the buoyancy
cannot be predicted.
•. Drugs that cause irritation and lesion to gastric mucosa are not suitable to be
formulated as FDDS.
8. FACTORS AFFECTING ON GASTRIC RETENTION
FDDS
Density
Posture
Age and
Gender
Fed or
Unfed
State
Size
8
9. MAJOR TYPES OF GASTRO RETENTIVE
DOSAGE FORMS/APPROACHES
GRDDS
BIO/MUCO-
ADHESIVE
SYSTEMS
FLOATING
DRUG
DELIVERY
SYSTEMS
EFFERVESCENT
SYSTEMS
NON
EFFERVESCENT
SYSTEM
HIGH
DENSITY
SYSTEMS
EXPANDAB
LE
SYSTEMS
SWELLING UNFOLDING
MAGNETIC
SYSTEMS
9
11. AIM AND OBJECTIVES
• To prepare Gastroretentive floating tablets of Cefadroxil by using
natural polymers
• To select the polymers to achieve desire sustained release effect.
• Preliminary trials using hydrophilic polymers, gas generating agent
or other excipients required for the formulation of the dosage forms
with the desired characteristics.
• Optimization of concentration of release retarding polymers.
• To study the effect of combination of polymers.
• To evaluate prepared batches of tablets.
• To perform model fitting.
11
12. NEED FOR CURRENT INVESTIGATION
• Drug that absorbed in the stomach
• Drug stable in acidic pH
• Drug which having short half life
• Drugs that are erratically absorbed due to variable gastric
emptying time
• Drug having low PPB
• Increases the drug efficiency by preventing the colonic
enzyme
12
13. • Literature survey
• Screening of drug and polymers
• Characterization of drug and polymers by IR, UV spectroscopy
• Selection of excipients for tablets
• Preparation of tablets of different formulation
• Optimization of concentration of gas generating agent
• Evaluation of tablets of different formulation
• Precompression parameters
Bulk Density
Tapped Density
Angle of Repose
Carr’s Index or % Compressibility
Hausner’s Ratio
Drug -Excipients Compatibility Study 13
PLAN OF WORK
14. Post compression parameters
Hardness
Thickness
Friability
%Drug content
Swelling index
Buoyancy lag time (BLT)
Total buoyancy period
In-vitro dissolution studies
• To study the release pattern of all formulation by model fitting
• Selection of the Best formulations
• Data collection & report writing
14
15. Category Name of component
API Cefadroxil
Binder PVP
Rate controlling polymer Gaur gum
Xanthan gum
Gas generating agent Sodium bicarbonate
Citric acid
Filler, Diluent Lactose
Lubricants, glidant Magnesium stearate, talc
DRUG & POLYMER PROFILE
15
MATERIALS AND METHODOLOGY
16. • Cefadroxil is almost completely absorbed from the stomach, food does not
interfere with its absorption.
• Half life - 1.5-2 hours
• Protien Binding - Protien binding rate of cefadroxil is 28.1%
• Solubility - soluble In water
• pH stability - 2.0 - 4.0
• Use - A urinary tract infection (UTI) is an infection of the bladder, kidneys,
ureters, or urethra,Strep throat, Staph infections, tonsillitis, skin infection
(acne).
• Antibiotics will not work for colds, flu, or other viral infections.
16
SELECTION OF DRUG
17. SELECTION OF NATURAL POLYMERS
• Xanthan gum is a stable material. Aqueous solutions are stable
over a wide pH range (pH 2– 12), although they demonstrate
maximum stability at pH 2–10 and temperatures of 10–60°C.
• Stable in the presence of enzymes, salts, acids, and bases.
• Nontoxic and non-irritant, soluble in cold or warm water.
• Good matrix forming agent.
• Low density polymer easy to float or having baunacy property
• Aqueous guar gum dispersions have stable at pH 2-10.5.
• Gaur gum also shows almost all properties as like xanthan
gum.
17
18. METHODOLOGY
• Direct compression technique
• Cefadroxil, lactose and hydrophilic polymers were passed from
sieve of # 40 and mixed for 10 min.
• Gas generating agent was then passed through sieve of # 60 added
to the above mixture.
• Magnesium stearate was passed through sieve of # 60 and added to
the above mixture.
• The whole bulk of powder was then mixed thoroughly for 15 min.
• The powder was then compressed into round shaped tablets on eight
station tablet press. The tablets were evaluated for parameters like
hardness and friability.
18
22. COMPATIBILITY STUDIES BETWEEN DRUG
AND POLYMER
22
CEFADROXIL PURE DRUG+XANTHAN GUM+GUAR GUM
FTIR Spectrum of CEFADROXIL PURE DRUG+XANTHAN GUM+GUAR GUM
23. INTERPRETATION OF DRUG AND POLYMER
Sr.no. Wavelength(cm-1) Interpretation
1 3416 C=O Stretching
2 2928 O-H stretching phenolic
3 1758 CONH Stretching
4 1684 N-H Stretching
5 1416 C-H stretching aromatic ring
6 1234 C-C stretching
23
Cefadroxil was found to be compatible with all the polymers as the all the
characteristic peaks of pure drug and polymers were seen in physical mixture
24. Formulation
code
Bulk
Density
(gm/ml)
Tap
Density
(gm/ml)
Carr’s
Index (%)
Hausner’s
ratio
Angle of
Repose
(Deg)
Flow Rates
(sec/ml)
F1 0.57 0.61 6.57 1.07 28.81 10.34
F2 0.55 0.60 8.33 1.09 27.02 11.56
F3 0.53 0.60 11 1.13 25.15 8.15
F4 058 0.65 10.7 1.12 21.79 10.56
F5 0.51 0.53 3.77 1.03 20.23 8.46
F6 0.53 0.58 8.60 1.09 23.25 9.29
F7 0.53 0.56 5.35 1.06 22.29 11.33
F8 0.55 0.58 6.12 1.08 20.33 9.25
F9 0.53 0.59 8.89 1.09 25.13 10.36
EVALUATION OF FORMULATION BLEND OF F1 – F9
BATCHES
24
Precompression Batches of F1-F9
28. Sr. No. Parameter Specification
1 Dissolution medium 900 ml 0.1 N HCL
2 Temperature 37±0.5⁰C
3 Speed of rotation 50 RPM
4 Volume withdrawn 5 ml withdrawn at time
interval.
5 λ max 230 nm
6 Tablet taken 3 tablets of each
formulation
• USP type-II dissolution test apparatus was used.
IN-VITRO DRUG RELEASE STUDY
28
33. CONCLUSION
• The effervescent floating tablets of Cefadroxil were successfully formulated
by using natural polymers and its combination for improving bioavailability of
Cefadroxil
• From the study, it has been concluded that, Xanthan gum and Guar gum can be
promising polymers for gastroretentive drug delivery system
• Drug-polymers compatibility study with FTIR, proved compatibility of
polymers used in formulation with the Cefadroxil
• The prepared floating tablets were evaluated for hardness, weight variation,
thickness, friability, drug content uniformity, buoyancy lag time, total floating
time, swelling index and in vitro dissolution studies.
• Among all the formulations F2 & F9 formulation batches were optimized
based on floating time and drug release profile.
• In formulations maximum swelling was seen with the formulation containing
Xanthan gum (F2) & Guar gum (F4). Results indicate that xanthan gum and
Gaur gum shows the good swelling index.
33
34. 34
• Among all the formulations, formulation F2 containing Xanthan gum &
formulation F9 containing Xanthan gum & Gaur gum showed maximum drug
release of 99.06% and 95.74% respectively at the end of 12 hr.
•The drug release from the optimized formulation followed zero order and
Korsmeyer peppas equation. Mechanism of drug release of Cefadroxil was found
mainly due to the polymer relaxation and diffusion rather than the erosion
•Based on the results of evaluations data of all the 9 formulations F2& F9 were
optimized because of their good sustained release data.
• Our objective to retain the dosage form for longer duration on gastric media have
fulfilled and it definitely give the sustain release action and it will definitely
increase its bioavailability.
35. 35
•Chein YW. Novel Drug Delivery Systems. 2nd ed. Revised and Expanded, Drugs and
Pharmaceutical Sciences, Volume-50, New York: Marcel Dekker Inc; 1992. p. 1-196.
•Lalla JK. Introduction to controlled release and oral controlled drug delivery system.
The Eastern Pharmacist 1991; 45; 25-28.
•Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics A treatise. 1st
ed. New Delhi: Vallabh Prakashan; 1995. p. 335-357.
• Vyas SP, Khar RK, editors. Controlled Drug Delivery Concept and Advances. 1st Ed.
New Delhi: Vallabh Prakashan; 2000. p. 1-6, 54, 155, 196.
•Lee TW, Robinson JR. Controlled-release drug-delivery systems. In: Gennaro A,
editor. Remington: The Science and Practice of Pharmacy. 20th ed. Pennsylvania: Mack
Publishing Company; 2001. p. 903-929.
•Aulton ME. Pharmaceutics: The Science of Dosage Form Design. 2nd ed. New York:
Livingstone Churchill Elsevier Science Ltd; 2002. p. 315-320.
References